HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AHCO

AdaptHealth Corp. (NASDAQ)

Healthcare — Medical Devices

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Buy 1.6 / 5 8 analysts
$10.97
$-0.24 (-2.14%)
Target: $14.00 (27.6%)
Sign in to add AHCO to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$1.45B
P/E Ratio (TTM)-
Forward P/E9.07
EPS (TTM)$-0.59
Dividend Yield-
Profit Margin-2.42%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation Buy 1.6
Analyst Target$14.00
Analysts8
Indexes NASDAQ

Technical Indicators

RSI (14)66.6
Beta1.46
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume$1.45M
Volume537.9K

Performance Analysis

BULLISH

AHCO shows predominantly bullish signals based on its fundamentals and technicals.

+ RSI at 66.6 shows positive momentum.
- Operating at a loss with -2.4% margin.
+ Wall Street consensus is "Buy" from 8 analysts.
+ Average analyst target of $14.00 implies 27.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 15:01 UTC

Back to Screener Export Report